Genzyme Ventures

Genzyme Ventures

Genzyme Ventures

Sanofi Genzyme has pioneered the development and delivery of transformative therapies for patients affected by rare and debilitating diseases for over 30 years.
Follow us
Alexa global traffic share
Twitter followers
Latest investments Show all
$35,988,360
Venture capital (Series B)
Fate Therapeutics Inc
$35,000,000
Venture capital (Series B)
bluebird bio
Team Size
1–10
Employees
Past year's investments

Genzyme Ventures participated in fewer than 3 rounds over the past year

Latest rounds
  • Fate Therapeutics Inc: Venture capital (Series B) ($36M)
  • bluebird bio: Venture capital (Series B) ($35M)
  • Proteostasis Therapeutics, Inc.: Venture capital (Series A) ($70.6M)